• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对阿尔茨海默病线粒体自噬分子途径的载脂蛋白E4干扰研究综述

A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease.

作者信息

Chen Huiyi, Chen Feng, Jiang Ying, Zhang Lu, Hu Guizhen, Sun Furong, Zhang Miaoping, Ji Yao, Chen Yanting, Che Gang, Zhou Xu, Zhang Yu

机构信息

Department of Children Rehabilitation, Yuebei People's Hospital, Affiliated Hospital of Shantou University Medical College, Shaoguan, China.

Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Department of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.

出版信息

Front Aging Neurosci. 2022 May 20;14:881239. doi: 10.3389/fnagi.2022.881239. eCollection 2022.

DOI:10.3389/fnagi.2022.881239
PMID:35669462
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9166238/
Abstract

Alzheimer's disease (AD) is one of the major worldwide causes of dementia that is characterized by irreversible decline in learning, memory loss, and behavioral impairments. Mitophagy is selective autophagy through the clearance of aberrant mitochondria, specifically for degradation to maintain energy generation and neuronal and synaptic function in the brain. Accumulating evidence shows that defective mitophagy is believed to be as one of the early and prominent features in AD pathogenesis and has drawn attention in the recent few years. ε4 allele is the greatest genetic determinant for AD and is widely reported to mediate detrimental effects on mitochondria function and mitophagic process. Given the continuity of the physiological process, this review takes the mitochondrial dynamic and mitophagic core events into consideration, which highlights the current knowledge about the molecular alterations from an -genotype perspective, synthesizes ApoE4-associated regulations, and the cross-talk between these signaling, along with the focuses on general autophagic process and several pivotal processes of mitophagy, including mitochondrial dynamic (DRP1, MFN-1), mitophagic induction (PINK1, Parkin). These may shed new light on the link between ApoE4 and AD and provide novel insights for promising mitophagy-targeted therapeutic strategies for AD.

摘要

阿尔茨海默病(AD)是全球范围内导致痴呆的主要原因之一,其特征为学习能力不可逆下降、记忆丧失和行为障碍。线粒体自噬是通过清除异常线粒体进行的选择性自噬,特别是为了维持大脑中的能量生成以及神经元和突触功能而进行降解。越来越多的证据表明,线粒体自噬缺陷被认为是AD发病机制中的早期突出特征之一,并在最近几年引起了关注。ε4等位基因是AD最大的遗传决定因素,广泛报道其对线粒体功能和线粒体自噬过程具有有害影响。鉴于生理过程的连续性,本综述考虑了线粒体动态变化和线粒体自噬的核心事件,从基因型角度突出了当前关于分子改变的知识,综合了载脂蛋白E4相关的调控以及这些信号之间的相互作用,同时关注一般自噬过程和线粒体自噬的几个关键过程,包括线粒体动态变化(动力蛋白1,线粒体融合蛋白1)、线粒体自噬诱导(PTEN诱导激酶1,帕金蛋白)。这些可能为载脂蛋白E4与AD之间的联系提供新的线索,并为有前景的针对线粒体自噬的AD治疗策略提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d239/9166238/275d72600e78/fnagi-14-881239-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d239/9166238/5713d2069947/fnagi-14-881239-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d239/9166238/275d72600e78/fnagi-14-881239-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d239/9166238/5713d2069947/fnagi-14-881239-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d239/9166238/275d72600e78/fnagi-14-881239-g0002.jpg

相似文献

1
A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease.针对阿尔茨海默病线粒体自噬分子途径的载脂蛋白E4干扰研究综述
Front Aging Neurosci. 2022 May 20;14:881239. doi: 10.3389/fnagi.2022.881239. eCollection 2022.
2
Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.淀粉样β和磷酸化 tau 诱导的阿尔茨海默病中的自噬和 mitophagy 缺陷。
Cells. 2019 May 22;8(5):488. doi: 10.3390/cells8050488.
3
Mitochondrial dysfunction, mitophagy, and role of dynamin-related protein 1 in Alzheimer's disease.线粒体功能障碍、线粒体自噬以及动力相关蛋白 1 在阿尔茨海默病中的作用。
J Neurosci Res. 2021 Apr;99(4):1120-1135. doi: 10.1002/jnr.24781. Epub 2021 Jan 19.
4
Aberrant mitochondrial morphology and function associated with impaired mitophagy and DNM1L-MAPK/ERK signaling are found in aged mutant Parkinsonian LRRK2 mice.在衰老的突变帕金森病 LRRK2 小鼠中发现了与受损的线粒体自噬和 DNM1L-MAPK/ERK 信号传导相关的异常线粒体形态和功能。
Autophagy. 2021 Oct;17(10):3196-3220. doi: 10.1080/15548627.2020.1850008. Epub 2020 Dec 10.
5
Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse.阿尔茨海默病中的缺陷性线粒体自噬和突触退化:聚焦于衰老、线粒体和突触。
Free Radic Biol Med. 2021 Aug 20;172:652-667. doi: 10.1016/j.freeradbiomed.2021.07.013. Epub 2021 Jul 8.
6
ApoE4 attenuates autophagy via FoxO3a repression in the brain.载脂蛋白 E4 通过抑制脑内 FoxO3a 来减弱自噬作用。
Sci Rep. 2021 Sep 2;11(1):17604. doi: 10.1038/s41598-021-97117-6.
7
Mitophagy in Alzheimer's disease: Molecular defects and therapeutic approaches.阿尔茨海默病中的自噬:分子缺陷与治疗方法。
Mol Psychiatry. 2023 Jan;28(1):202-216. doi: 10.1038/s41380-022-01631-6. Epub 2022 Jun 3.
8
PINK1 Activation Attenuates Impaired Neuronal-Like Differentiation and Synaptogenesis and Mitochondrial Dysfunction in Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.PINK1 激活可减轻阿尔茨海默病跨线粒体细胞系中受损的神经元样分化和突触发生以及线粒体功能障碍。
J Alzheimers Dis. 2021;81(4):1749-1761. doi: 10.3233/JAD-210095.
9
APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.载脂蛋白 E 与阿尔茨海默病:越来越多的证据表明,针对载脂蛋白 E4 可能有助于对抗阿尔茨海默病的发病机制。
Mol Neurobiol. 2019 Apr;56(4):2450-2465. doi: 10.1007/s12035-018-1237-z. Epub 2018 Jul 21.
10
Mitophagy in neurodegenerative disease pathogenesis.神经退行性疾病发病机制中的线粒体自噬
Neural Regen Res. 2024 May;19(5):998-1005. doi: 10.4103/1673-5374.385281.

引用本文的文献

1
The Role of Genetic, Environmental, and Dietary Factors in Alzheimer's Disease: A Narrative Review.遗传、环境和饮食因素在阿尔茨海默病中的作用:一项叙述性综述
Int J Mol Sci. 2025 Jan 30;26(3):1222. doi: 10.3390/ijms26031222.
2
ApoE4 dysregulation incites depressive symptoms and mitochondrial impairments in mice.载脂蛋白 E4 失调会引发小鼠的抑郁症状和线粒体损伤。
J Cell Mol Med. 2024 Apr;28(7):e18160. doi: 10.1111/jcmm.18160.
3
Presenilin2 D439A Mutation Induces Dysfunction of Mitochondrial Fusion/Fission Dynamics and Abnormal Regulation of GTPase Activity.

本文引用的文献

1
Isoform-dependent lysosomal degradation and internalization of apolipoprotein E requires autophagy proteins.载脂蛋白 E 的异构体依赖性溶酶体降解和内化需要自噬蛋白。
J Cell Sci. 2022 Jan 15;135(2). doi: 10.1242/jcs.258687. Epub 2022 Jan 25.
2
Mitochondrial Deficits With Neural and Social Damage in Early-Stage Alzheimer's Disease Model Mice.早期阿尔茨海默病模型小鼠中伴有神经和社交损伤的线粒体缺陷
Front Aging Neurosci. 2021 Dec 10;13:748388. doi: 10.3389/fnagi.2021.748388. eCollection 2021.
3
Mitochondrial Dynamics: Pathogenesis and Therapeutic Targets of Vascular Diseases.
早老素 2 D439A 突变诱导线粒体融合/裂变动力学功能障碍和 GTP 酶活性的异常调节。
Mol Neurobiol. 2024 Aug;61(8):5047-5070. doi: 10.1007/s12035-023-03858-y. Epub 2023 Dec 30.
4
APOE Peripheral and Brain Impact: APOE4 Carriers Accelerate Their Alzheimer Continuum and Have a High Risk of Suicide in PM Polluted Cities.载脂蛋白 E 外周和大脑影响:载脂蛋白 E4 携带者加速其阿尔茨海默病连续体,并在 PM 污染城市有高自杀风险。
Biomolecules. 2023 May 31;13(6):927. doi: 10.3390/biom13060927.
5
Neuronal ApoE4 in Alzheimer's disease and potential therapeutic targets.阿尔茨海默病中的神经元载脂蛋白E4及潜在治疗靶点。
Front Aging Neurosci. 2023 Jun 2;15:1199434. doi: 10.3389/fnagi.2023.1199434. eCollection 2023.
6
Apoe4 and Alzheimer's Disease Pathogenesis-Mitochondrial Deregulation and Targeted Therapeutic Strategies.载脂蛋白 E4 与阿尔茨海默病发病机制-线粒体失调与靶向治疗策略。
Int J Mol Sci. 2023 Jan 1;24(1):778. doi: 10.3390/ijms24010778.
7
Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer's Disease and Identifying Promising Drug Targets.将阿尔茨海默病的淀粉样蛋白、tau 和线粒体假说联系起来,并确定有前途的药物靶点。
Biomolecules. 2022 Nov 11;12(11):1676. doi: 10.3390/biom12111676.
线粒体动力学:血管疾病的发病机制与治疗靶点
Front Cardiovasc Med. 2021 Dec 6;8:770574. doi: 10.3389/fcvm.2021.770574. eCollection 2021.
4
Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention.用于阿尔茨海默病诊断、治疗和预防的生物标志物。
Ageing Res Rev. 2022 Feb;74:101544. doi: 10.1016/j.arr.2021.101544. Epub 2021 Dec 18.
5
BNIP3L/NIX-mediated mitophagy: molecular mechanisms and implications for human disease.BNIP3L/NIX 介导的线粒体自噬:分子机制及其与人类疾病的关系。
Cell Death Dis. 2021 Dec 20;13(1):14. doi: 10.1038/s41419-021-04469-y.
6
A partial reduction of Drp1 improves cognitive behavior and enhances mitophagy, autophagy and dendritic spines in a transgenic Tau mouse model of Alzheimer disease.在阿尔茨海默病转基因 Tau 小鼠模型中,Drp1 的部分减少可改善认知行为,并增强线粒体自噬、自噬和树突棘。
Hum Mol Genet. 2022 Jun 4;31(11):1788-1805. doi: 10.1093/hmg/ddab360.
7
CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma.CDK9 抑制通过调节 SIRT1-FOXO3-BNIP3 轴阻断 PINK1-PRKN 介导的线粒体自噬的起始,增强涉及肝癌线粒体功能障碍的治疗效果。
Autophagy. 2022 Aug;18(8):1879-1897. doi: 10.1080/15548627.2021.2007027. Epub 2021 Dec 10.
8
Genetic mutations of APOEε4 carriers in cardiovascular patients lead to the development of insulin resistance and risk of Alzheimer's disease.载脂蛋白 Eε4 基因突变导致心血管病患者胰岛素抵抗和阿尔茨海默病风险增加。
J Biochem Mol Toxicol. 2022 Feb;36(2):e22953. doi: 10.1002/jbt.22953. Epub 2021 Nov 10.
9
APOE, TOMM40, and sex interactions on neural network connectivity.载脂蛋白 E、 TOMM40 与神经网络连接的性别相互作用。
Neurobiol Aging. 2022 Jan;109:158-165. doi: 10.1016/j.neurobiolaging.2021.09.020. Epub 2021 Sep 30.
10
Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer's Disease.针对阿尔茨海默病线粒体功能障碍的分子途径及治疗意义的最新进展
Mol Neurobiol. 2022 Jan;59(1):535-555. doi: 10.1007/s12035-021-02612-6. Epub 2021 Nov 2.